Novo Nordisk sues Hims & Hers over compounded obesity drugs
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4,…
Tag: obesity
Pfizer execs talk Metsera obesity drug
Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York…
Pfizer’s monthly obesity injection drove shows promise in trial
Smith Collection | Archive Photos | Getty Images Pfizer on Thursday said its experimental obesity drug, which it acquired through…
Goldman's Haider: Pivotal Year for Obesity Market in Pharma
Asad Haider, head of the U.S. Healthcare Business Unit at Goldman Sachs Research, says 2026 is a pivotal year for…
Eli Lilly plans $3.5 billion Pennsylvania plant for obesity drugs
Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025. Antranik Tavitian |…
Eli Lilly CEO David Ricks talks Medicare coverage of obesity pills
Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for…
Novo Must Guard Against Obesity Drug Price War, Chairman Says
Novo Nordisk A/S’s chairman said the Danish drugmaker must protect its obesity business from being eroded with falling prices, as…
Structure Therapeutics CEO on obesity pill and more
Ray Stevens, chief executive officer of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in…
Novo Nordisk shares rise after Wegovy obesity pill launch
A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, US, on Thursday, Jan. 15, 2026.…
AstraZeneca CFO on M&A Strategy and Obesity Market
AstraZeneca CFO Aradhana Sarin discusses the company’s M&A strategy and weight-loss portfolio with Katie Greifeld at the JPMorgan Health-Care Conference…